Breaking News, Financial News

Financial Reports: Abbott 1Q

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

1Q Revenues: $9.4 billion (+4%) 1Q Earnings: $1.2 billion (+44%) Comments: Proprietary pharma revenues were up 7% to $4.1 billion, driven by Humira (+17% to $1.9 billion). The established pharma revenues (ex-U.S.) was down 2% to $1.3 billion....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters